Table 1 GMP requirements for radiopharmaceutical production for clinical trials in Europe
From: Position statement on radiopharmaceutical production for clinical trials
IMP | Non-IMP | Diagnostic | Therapeutic | Profit | Non-profit | Public | Private | |
|---|---|---|---|---|---|---|---|---|
Spain | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
Italy | Yes | Yes | No | Yes | Yes | No | Yes | Yes |
UK | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
France | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes |
Germany | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes |
The Netherlands | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
Belgium | Yes | No | YES | YES | YES | YES | YES | YES |